Literature DB >> 33330779

Challenges of COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan: a real-world story.

Hanako Jimi1, Gaku Hashimoto2.   

Abstract

The event of the Diamond Princess, with a total of 712 (as of 17 March 2020) persons infected on the cruise ship, attracted global attention as the largest disease cluster outside China for the period 7 to 24 February 2020. Representing the Ministry of Health, Labour and Welfare, the authors were heavily engaged in the quarantine operation on the cruise ship ourselves. During the quarantine period from 5 to 23 February 2020, when the last group of the quarantined passengers left the ship, a series of measures have been conducted under the principles of i) zero deaths among all on board, ii) rapid establishment and thorough implementation of an infection control system, and iii) maintenance of health conditions and relief of anxieties among passengers and crew members. The case of Diamond Princess has implications of more than a cruise ship but deserves full scientific analysis to learn lessons from this operation as well as to study the characteristics, particularly the transmission of COVID-19. 2020, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; Diamond Princess; cruise ship; quarantine

Year:  2020        PMID: 33330779      PMCID: PMC7731266          DOI: 10.35772/ghm.2020.01038

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  7 in total

1.  Mental health needs associated with COVID-19 on the diamond princess cruise ship: A case series recorded by the disaster psychiatric assistance team.

Authors:  Hirokazu Tachikawa; Tatsuhiko Kubo; Sayaka Gomei; Sho Takahashi; Yuzuru Kawashima; Kazunori Manaka; Akira Mori; Hisayoshi Kondo; Yuichi Koido; Hiromi Ishikawa; Taku Otsuru; Wataru Nogi
Journal:  Int J Disaster Risk Reduct       Date:  2022-08-20       Impact factor: 4.842

2.  Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination.

Authors:  Yuri Uchiyama; Hirotaka Fukasawa; Yuri Ishino; Daisuke Nakagami; Mai Kaneko; Hideo Yasuda; Ryuichi Furuya
Journal:  BMC Nephrol       Date:  2022-06-21       Impact factor: 2.585

3.  Study Protocol and Preliminary Results of the Impact of Occupational Health Workers' Activities on Their Health: Nationwide Prospective Internet-Based Survey.

Authors:  Kazunori Ikegami; Yasuro Yoshimoto; Hiroka Baba; Shingo Sekoguchi; Hajime Ando; Akira Ogami
Journal:  JMIR Form Res       Date:  2022-07-28

Review 4.  Systematic Review on Outbreaks of SARS-CoV-2 on Cruise, Navy and Cargo Ships.

Authors:  Ann-Christin Kordsmeyer; Natascha Mojtahedzadeh; Jan Heidrich; Kristina Militzer; Thomas von Münster; Lukas Belz; Hans-Joachim Jensen; Sinan Bakir; Esther Henning; Julian Heuser; Angelina Klein; Nadine Sproessel; Axel Ekkernkamp; Lena Ehlers; Jens de Boer; Scarlett Kleine-Kampmann; Martin Dirksen-Fischer; Anita Plenge-Bönig; Volker Harth; Marcus Oldenburg
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

5.  ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.

Authors:  Agnès Marchio; Christophe Batejat; Jessica Vanhomwegen; Maxence Feher; Quentin Grassin; Maxime Chazal; Olivia Raulin; Anne Farges-Berth; Florence Reibel; Vincent Estève; Anne Dejean; Nolwenn Jouvenet; Jean-Claude Manuguerra; Pascal Pineau
Journal:  Arch Virol       Date:  2021-07-12       Impact factor: 2.574

6.  Perceptions of the COVID-19 pandemic in Japan with respect to cultural, information, disaster and social issues.

Authors:  Anawat Suppasri; Miwako Kitamura; Haruka Tsukuda; Sebastien P Boret; Gianluca Pescaroli; Yasuaki Onoda; Fumihiko Imamura; David Alexander; Natt Leelawat
Journal:  Prog Disaster Sci       Date:  2021-03-02

7.  Post-traumatic stress symptoms among medical rescue workers exposed to COVID-19 in Japan.

Authors:  Hiroki Asaoka; Yuichi Koido; Yuzuru Kawashima; Miki Ikeda; Yuki Miyamoto; Daisuke Nishi
Journal:  Psychiatry Clin Neurosci       Date:  2020-07-21       Impact factor: 12.145

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.